|
Press Release DOVEBID® TO CONDUCT BIO/PHARMA EXCHANGE AUCTION FEATURING PFIZER, INC. AND SUGEN, INC. FOSTER CITY, CA (August 11, 2004) - DoveBid, Inc., a global provider of capital asset auction and valuation services, announced today they will conduct Bio/Pharma Exchange #9, a two-day online auction featuring biotechnology and pharmaceutical research and development equipment from Pfizer, Inc., Sugen, Inc., AxCell Biosciences, and other biotechnology companies. This ninth in a series of Bio/Pharma Exchanges will be conducted over the Internet at DoveBid’s Website on August 25, 2004 beginning at 12:00 a.m. midnight Pacific Time. This auction will feature a wide range of quality equipment, including compound and inverted microscopes, DNA sequencers, electrolyte analyzers, lab equipment, and more. The Bio/Pharma Exchange #9 is another example of DoveBid's Global Auction Exchange program, where multiple sellers consign assets together into auction events, to gain broad asset exposure to a global audience of buyers. Participants may bid online. Detailed preview information, asset catalog, and online bidding instructions are available at www.dovebid.com. There are an additional 100+ upcoming auctions on DoveBid’s calendar. For a complete list of our auctions, equipment asset catalogs, and brochures, please visit DoveBid’s Website at www.dovebid.com. About DoveBid® # # # DoveBid Contact: |
